AGIOS PHARMACEUTICALS, INC. Contracts Receivable, Claims and Uncertain Amounts
AGIOS PHARMACEUTICALS, INC. (AGIO) had Contracts Receivable, Claims and Uncertain Amounts of $7.90 million as of 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Notes
us-gaap:ContractsReceivableClaimsAndUncertainAmounts · last filed 2016-08-08
- 2016-06-30: Contracts Receivable, Claims and Uncertain Amounts $7.90M.
- 2016-03-31: Contracts Receivable, Claims and Uncertain Amounts $6.80M.
- 2015-12-31: Contracts Receivable, Claims and Uncertain Amounts $8.20M.
- 2015-09-30: Contracts Receivable, Claims and Uncertain Amounts $9.10M.
| Period end | Contracts Receivable, Claims and Uncertain Amounts |
|---|---|
| 2016-06-30 | $7.90M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $6.80M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $8.20M 10-Q · filed 2016-08-08 |
| 2015-09-30 | $9.10M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $10.50M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $7.00M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $6.50M 10-K · filed 2016-02-26 |
| 2014-09-30 | $18.70M 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |